Compare Walt Disney Co (DIS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Walt Disney Co vs Zimmer Biomet Holdings Inc — how do they compare? Walt Disney Co trades at $97.42 (market cap $166.48B), while Zimmer Biomet Holdings Inc trades at $90.17 (market cap $17.61B). The key difference: Walt Disney Co is far larger — about 9.5× Zimmer Biomet Holdings Inc's market cap, and Walt Disney Co pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| DIS | ZBH | |
|---|---|---|
Market Cap | $166.48B | $17.61B |
Volume | 7,546,013 | — |
Sector | Media | Health |
52-Week High | $122.94 | $107.71 |
52-Week Low | $92.40 | $79.58 |
Enterprise Value | $208.16B | $24.66B |
Dividend Yield | 1.56% | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Disney (DIS) trades at $95.87, down 0.15% on the day, with strong fundamental performance including three consecutive earnings beats and improving profitability. The stock shows bearish technical signals but maintains solid analyst support with a $125.60 consensus price target representing 31% upside potential. Recent developments include Super Bowl advertising opportunities and theme park investments starting to yield returns.
Disney presents a compelling value opportunity with reasonable valuation multiples and strong cash flow generation, though facing near-term technical headwinds. Key risks include box office underperformance and regulatory challenges, while catalysts include major sporting events and streaming integration. The fundamental improvement trajectory supports the bullish analyst consensus despite current price weakness.
Zimmer Biomet (ZBH) trades at $94.08, up 3.0% in the past 24 hours, near its consensus price target of $97.67. The stock shows bullish technical signals with strong moving average support and has consistently beaten earnings estimates in recent quarters. Revenue grew to $8.23B in 2025, though net income margin declined to 8.56%. Recent corporate developments include expansion in Asia Pacific and a planned $1 billion share repurchase program in 2026.
ZBH presents a balanced outlook with steady revenue growth and shareholder returns via dividends and buybacks, but faces risks from margin compression and rising debt. Analyst sentiment is mixed with 40% buy ratings, suggesting moderate upside potential with caution around profitability trends and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Walt Disney Co
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
